⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 20, 1997Circulation

Fibrinolytic Variables and Cardiovascular Prognosisin Patients With Stable Angina Pectoris Treated With Verapamil or Metoprolol

View Full Paper

Ask AI

Bookmark

Share

Authors

CHClaes HeldGeneral Cardiology PHPaul HjemdahlPreventive Cardiology NRNina RehnqvistUniversity of Udine

Discussion

Loading...

Member takes

Implication

Fibrinolytic measures may refine CV risk stratification in stable angina; leaves open whether modulating fibrinolysis alters outcomes.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Held et al. (1997) studied this question.

synapsesocial.com/papers/6a210341fd1130a429f64dad https://doi.org/10.1161/01.cir.95.10.2380

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Effects of metoprolol vs verapamil in patients with stable angina pectoris: The Angina Prognosis Study in Stockholm (APSIS)1996 · 220 citations
2Influence of Metoprolol CR/ZOK on Plasminogen Activator Inhibitor (PAI‐1) in Man: A Pilot Study1990 · 25 citations
3Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up.1993 · 241 citations
4Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study In Stockholm (APSIS). A comparison with healthy controls1997 · 46 citations
5ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography1993 · 141 citations